Abstract: The present disclosure relates to water dispersible granular pesticide compositions, and methods of making and using the compositions. The pesticide compositions include an inner layer including a first pesticide coated on to a substrate, and an outer layer comprising a second pesticide coated on the inner layer. The outer layer increases the water dispersibility of the granular composition, and protects the first pesticide against hydrolysis and photolysis.

Abstract: The present invention relates to a novel use of herbal extracts in a pharmaceutical composition for prevention and treatment of nephritis and, more particularly, to a pharmaceutical composition and a health functional food for prevention and/or treatment of nephritis that contains at least one herbal extract selected from the group consisting of a Crataegi Fructus extract, a Cinnamomi Cortex extract, a Prunella Spica extract, and an Equiseti Herba extract, a method for prevention and/or treatment of nephritis using the herbal extract, and a use of the herbal extract in preparation of a composition for prevention and/or treatment of nephritis. The herbal extract has a good therapeutic effect for nephritis on a nephritis model of which the nephritis is induced by a drug such as gentamicin, cisplatin, etc., and a good inhibitory activity on the growth of mesangial cells in kidneys, thereby providing a very useful means for prevention and/or treatment of nephritis.

Abstract: A topical composition according to the present invention for use in a skin care regimen that provides matrix metalloprotease (MMP) inhibiting activity, tissue inhibitor of metalloprotease (TIMP) inducing activity, and immediate and delayed antioxidative activity. Preferably, the topical composition comprises at least one MMP inhibitor, a TIMP inducing agent, Tremella fuciformis (snow fungus) extract, Camellia sinensis (green tea) leaf extract, and Eugenia caryophyllus (clove) extract. The compositions are useful in anti-wrinkle and anti-aging products, providing elasticity, firmness, tone and texture to the skin, ameliorating fine lines and preventing skin damage.

Abstract: A weight loss product comprises a mixture of Alchemilla vulgaris, Olea europaea, Cuminum cyminum, and Mentha longiflora (in the weight proportion 12:10:5:4), to which additional ingredients have been added to increase weight loss efficacy.

Abstract: This invention provides a method for identifying a composition of Cinnamomi and Poria. This invention further provides a composition comprising: Ramulus Cinnamomi, Poria Cortex, Moutan Radicis, Radix Paeonize Alba, and Semen Persicae. This invention provides various uses of these compositions.

Abstract: Antimicrobial compositions based on a combination or blend of plant essential oils is of enhanced antimicrobial effectiveness; by adding to the combination of at least two plant essential oils, and preferably adds a small but antimicrobial enhancing effective amount of an enhancer selected from the group consisting of polyionic organic enhancers and polyionic inorganic enhancers. One preferred blended oil composition is a mixture of plant essential oils wherein at least one of the oils is oregano oil. The oil blend is used as a major component in the finished product anti-microbial.

Abstract: The methods and compositions of the present invention are directed to the treatment or amelioration of muscle cramps using a composition that includes one or more TRPV1 channel activators, and/or one or more TRPA1 channel activators, and/or one or more ASIC channel activators.

Abstract: Compositions containing one or more derivatives of essential oil compounds for use in personal care compositions, such as compositions for oral, throat and skin care are disclosed. These derivatives include acetals of parent essential oil aldehydes and ketones; esters or ethers of parent essential oil alcohols and phenolics; and esters of parent essential oil acids. Examples of parent essential oil aldehydes and ketones include citral, cinnamic aldehyde, ?-anisaldehyde, vanillin, ethyl vanillin, heliotropin, carvone, and menthone. Examples of parent essential oil alcohols and phenolics include thymol, eugenol, isoeugenol, dihydroeugenol, carvacrol, carveol, geraniol, nerol, vanillyl alcohol, heliotropyl alcohol, ?-anisyl alcohol, cinnamyl alcohol and ?-ionol. Examples of parent essential oil acids include ?-anisic acid, cinnamic acid, vanillic acid and geranic acid.

Abstract: Compositions for cleaning, disinfecting and sanitizing are described. The compositions comprise essential oils and are stable, non-toxic and environmentally sustainable. Also disclosed are deodorants and scalp refreshers having these properties.

Abstract: A non-toxic insect repellent concentrate formulation utilizing a plurality of all natural active components has been proven to be effective in repelling mosquitoes for periods of between six to eight weeks, with one application. The insect repellent concentrate formulation includes a plurality of natural essential oils comprising at least one emulsifying agent to maintain the oils in a stable solution. A pH conditioning agent may be added to assure the formulation is pH balanced for application to grass, plants, and trees, without detriment. The formulation may be provided as either a concentrate, or at dilutions ready for direct application, and may be applied by any of a variety of methods including broadcast spraying, boom applicators, misting systems, aerosol spray devices, etc.

Abstract: Disclosed are dietary supplements comprising a combination of a spice, a partially purified phytochemical, and a fully purified phytochemical that synergistically downregulates inflammation and promotes wellness, good health, and fitness in a mammal. Methods of identifying and making such supplements are likewise provided. The method of identifying comprises contacting mammalian cells, in vitro or in vivo, with the combination, assaying to detect a change in the level of a biomarker that is correlated with downregulation of an inflammatory response of the cells, and identifying a phytochemical composition comprising a combination of spices that synergistically changes the level of the biomarker. Exemplary supplements include a combination of spices selected from (a) turmeric and ginger, (b) turmeric and capsicum, and (c) paprika and nutmeg.

Abstract: The present invention discloses a non-toxic, long-lasting tire dressing with pet repellent qualities which enhances the appearance of a vehicle's tires while deterring animals from urinating on the tires. The present invention relates to a new pet repellent tire dressing includes silicone, a solvent, citronella oil, cinnamon oil, and piper nigrum oil. In one embodiment, the citronella oil ranges from about 0.1% to 4% by weight, the cinnamon oil ranges from about 0.04% to 1.6% of the solution by weight, the piper nigrum oil ranges from about 0.01% to 0.4% of the solution, by weight, a solvent and silicone. In one embodiment, the pet repellent tire dressing also includes a dye up to the amount of 0.02% by weight.

Abstract: The air-refreshing disinfectants currently sold in the market mostly contain artificially synthesized chemical disinfectants. Frequent exposure to the air containing such chemicals may be somewhat harmful to the human body. Therefore the present invention provides an air-refreshing disinfectant, and in particular an air-refreshing disinfectant which is not chemically synthesized and takes natural materials as raw materials and traditional Chinese medicinal volatile oils as main effective ingredients. It is characterized by bacteriostatic and antiviral effects, long-lasting fragrance and cost-effectiveness, and is beneficial to human health. To achieve this objective, the present invention, by taking advantage of the bacteriostatic, antiviral and fragrant characteristics of traditional Chinese medicinal volatile oils, employs specific combinations of eucalyptus oil, clove oil, patchouli oil, forsythia oil and schizonepeta oil as the active ingredients of the air-refreshing disinfectant.

Abstract: Materials derived from cinnamon can be administered orally to humans or animals for the purpose of controlling blood glucose as well improving glucose tolerance. Controlling glucose metabolism is essential for those with impaired glucose metabolism as is the case for those with Type II diabetes where insulin function is not properly functioning. Such administration can also be used for the purpose of enhancing nutrient transport for purposes of athletic performance and controlling bodyweight and body fat levels. Similarly related, such administration can also be used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material can be administered as extracts of cinnamon and can be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.

Abstract: Provided are methods for extracting flavor and fragrance materials from natural plant materials, using poly(trimethylene ether) glycol homopolymers and copolymers. The poly(trimethylene ether) glycol homopolymers and copolymers act as solubilizers for essential oils, and can be used to provide compositions having a variety of uses in applications such as cosmetics, personal care products, and industrial cleaning products.

Abstract: The present invention concerns the pharmaceutical and cosmetic application of biocolloids, which originate from the mixture of a nanoemulsion and at least one water-soluble plant extract such as an extract from Mahonia aquifolium, wherein the biological effect of the plant ingredients is enhanced by the composition although the nanoemulsion does not function as a carrier system. The biocolloids are especially for the treatment and care of the skin.

Abstract: Pregnane glycoside or a Caralluma extract including the pregnane glycoside of the present invention can be used for medical purposes and as food additives, such as a treatment of obesity, a reduction of blood glucose, a reduction of blood pressure, a reduction in hip, waist and arm circumferences, a reduction of fat, increase of BMR, a decrease of BMI, an increase of lean body mass, an appetite-suppression and a reduction/elimination of joint pain, anti-aging, a treatment for falling sex drive, the treatment for impotency and an erectile dysfunction, and an enhancement of energy levels.

Abstract: A novel pest repellant and pesticide composition for use in repelling, and in some cases exterminating, reptiles, rodents, insects (including bed bugs), and other unwanted pests. Advantageously, this pest repellant and pesticide composition is safe, effective, economical to produce, and environmentally-friendly. The novel pest repellant and pesticide composition includes: between about 0.5% and 5.0% by weight cinnamon oil; between about 0.1% and 2.0% by weight sodium lauryl sulfate; between about 0.1% and 2.0% by weight citric acid; and between about 90.0% and 98.0% by weight inert ingredients. Optionally, the novel pest repellant and pesticide composition also includes between about 1.0% and 5.0% by weight garlic oil. Optionally, the inert ingredients include one or more of water and diatomaceous earth.

Abstract: The invention relates to a substance for restoring normal co-expression and interaction between the LOX and NRAGE proteins. The invention relates in particular to the use of an effective amount of at least one substance that modulates the expression and/or activity of LOX of sequence ID no. 1, and/or that modulates the expression and/or activity of NRAGE of sequence ID no. 2, for the manufacture of a composition for modulating the interaction between the LOX and NRAGE proteins in order to regulate the balance between the cellular phenomena of proliferation, differentiation and apoptosis, particularly in cases where the balance between these phenomena is disturbed, and especially in cases where the interaction between LOX and NRAGE is absent or altered.

Abstract: Method of selecting and preparing medical devices comprising extracts of plants and natural substances devoid of pharmacologically, immunologically or metabolically active fractions and characterised by a content of substances able to exert beneficial effects on the body, mediated by mechanical or physical effects, which said process comprises: a) removal by conventional processes of any pharmacologically, immunologically or metabolically active fractions from extracts of plants or natural substances; b) biological testing to establish that the extract or substance obtained in a) is devoid of pharmacological, metabolic and immunological effects; c) formulation of the extracts or substances that pass the test conducted at stage b) into suitable medical devices.

Abstract: A synergistic mixture (which may be utilized as a food or a drink or a supplement or a drug or a cosmetic or a hygienic product) that is formulated and is capable of improving a person's well being, lowering the risks of cardiovascular and/or Alzheimer's diseases and/or lowering blood sugar using natural and synthetic ingredients. Numerous ratios may be formulated for aroma, color, flavor, flow (viscosity), taste and uniformity. Moreover, ingredients for sugar substitutes, natural preservatives, nano-dispersion, nano-emulsion, nano-encapsulation of ingredients and apparatus for personalized nutrition are also described herein.

Abstract: This invention relates to a composition and method for controlling blood glucose levels in patients with diabetes. An object of the present invention is to provide new herbal formulations for the treatment of diabetes, especially type 2 diabetes. In particular, the preparation and administration of herbal formulations comprising cinnamon and Gymnema sylvestre extract are described herein. An herbal formulation comprising Gymnema sylvestre extract, cinnamon extract, hydroxypropylcellulose, magnesium stearate, calcium phosphate, gelatine, and iron and titanium oxide exhibited improved control of type 2 diabetes as compared to the placebo group in clinical trials.

Abstract: The present invention provides a Cinnamomum subavenium extract for inhibiting melanogenesis. The present invention also provides a composition for inhibiting melanogenesis including compounds inhibit tyrosinase activity.

Abstract: A composition of ingestible ingredients containing a first ingestible ingredient which has an undesired effect on the human body when ingested, wherein preferably the ingredient is sugar and the undesired effect is blood sugar fluctuations which can lead to diabetes, and at least one other ingestible ingredient which reduces the impact or the undesired effect of the first ingestible ingredient, wherein the other ingredient is either cinnamon or polyphenols from cinnamon, or ginseng or ginsenosides from ginseng. The composition may be in a package, a bulk mix or a product.

Abstract: The present invention relates to a composition inhibiting or destroying at least one living or unicellular organism, which comprises at least one anti-infectious agent and at least one activating agent containing at least one metal element, together with at least one dispersing agent. The present invention also relates to the utilization of such a composition.

Abstract: A herbal medicinal composition, an extract thereof, and a method of manufacturing the same are disclosed. The herbal medicinal composition may be used to induce proliferation of cranial nerve cells, and it includes: 1.5-6 parts by weight of Salvia Radix, 1.5-6 parts by weight of Atractylodis Rhizoma, 1.5-6 parts by weight of Poria, 1.5-6 parts by weight of Glycyrrhizae Radix, 1.5-6 parts by weight of Angelicae Radix, 1.5-6 parts by weight of Paeoniae (Ovatae) Radix Rubra, 1.5-6 parts by weight of Ligustici Rhizoma, 1.5-6 parts by weight of Rehmanniae Radix, 2.5-10 parts by weight of Aconiti Tuber, 1.5-6 parts by weight of Zingiberis Rhizoma, 1.5-6 parts by weight of Scutellariae Radix, 2.5-10 parts by weight of Cinnamon Seed, 10-40 parts by weight of Astragali Radix, 1.5-6 parts by weight of Cinnamomum Ramulus, and 1.5-6 parts by weight of Ginseng Radix.

Abstract: Materials derived from cinnamon can be administered orally to humans or animals for the purpose of controlling blood glucose as well improving glucose tolerance. Controlling glucose metabolism is essential for those with impaired glucose metabolism as is the case for those with Type II diabetes where insulin function is not properly functioning. Such administration can also be used for the purpose of enhancing nutrient transport for purposes of athletic performance and controlling bodyweight and body fat levels. Similarly related, such administration can also be used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material can be administered as extracts of cinnamon and can be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.

Abstract: The present application disclosed the use of a cinnamon extract in the treatment of amyloid-associated diseases and disorders, such as Alzheimer's disease.

Abstract: The invention is directed to a topical insect repellent with extended duration of protection and that was obtained by combining natural and organic plant essential oil compounds. The new natural repellent exhibits the longevity and repellency that is comparable to or better than N,N-diethyl-m-toluamide (DEET), a synthetic compound employed in almost all commercial formulations, while at the same time is more acceptable than DEET, which has an unpleasant odor, imparts a greasy feel to the skin, and carries certain health concerns when used on children. The inventive insect repellent, formulated in a suitable carrier repels and incapacitates flying insects and other pests, such as mosquitoes and other biting flies or insects, thus demonstrating the utility of the novel insect repellent for protecting pets and livestock as well as humans.

Abstract: A herbal extract composition from Lythraceae and Lauraceae family plants and its usage as insulin resistance reducer, syndrome X normalization, pre-diabetes and type 2 diabetes treatments, particularly as activator in insulin signal pathway, as modulator in glucose transport system, as modulator in adiponectin secretion, and as suppressor in insulin resistance. Representative from Lythraceae family has been selected Lagerstroemia speciosa, and representative from Lauraceae family has been selected Cinnamomum burmannii. Such herbal extract composition work synergistically to strengthen pharmacological effect produced by each extract if they act alone.

Abstract: Pregnane glycoside or a Caralluma extract including the pregnane glycoside of the present invention can be used for medical purposes and as food additives, such as a treatment of obesity, a reduction of blood glucose, a reduction of blood pressure, a reduction in hip, waist and arm circumferences, a reduction of fat, increase of BMR, a decrease of BMI, an increase of lean body mass, an appetite-suppression and a reduction/elimination of joint pain, anti-aging, a treatment for falling sex drive, the treatment for impotency and an erectile dysfunction, and an enhancement of energy levels.

Abstract: The present invention relates to herbal medicinal compositions and extracts thereof for inhibiting growth of cancer cells. One of the examples described in the present invention comprises Forsythiae fructus, Menthae Herba, Gardeniae Fructus, Scutellariae Radix, Lophatheri Folium, Glycyrrhizae Radix, Rhei Rhizoma, Na2SO4, and Atractylodis Rhizoma. The residual examples are described herein.

Abstract: A new treatment for individuals suffering from type 2 diabetes. The formulation used in the treatment includes a mixture of a thiazoleineione, an insulin, cinnamon bark extract, and at least one synergistic supplement selected from the group consisting of blueberry leaf extract, cranberry extract, kelp extract, sugar sea beet extract, acerola berry extract; ginger root extract, black cherry extract, green tea extract, Irish moss extract, aloe vera extract, and Stevia leaf extract. The thiazoleineione is preferably pioglitazone. The insulin is preferably an Insulin Aspart of rDNA origin. It is preferred that the cinnamon bark extract and synergistic supplement be in the form of a liquid concentrate.

Abstract: The present invention relates to an aroma therapy patch including a herbal layer containing herbal extract which is formed on one surface of a substrate having a specific shape, and an adhesive layer formed on the other surface of the substrate, wherein at least one surface of the substrate is colored. The aroma therapy patch of the present invention exerts aromatic effects by the actions of herbal extracts as well as chromatherapeutic effects induced by a specific color used therein, which can be used easily and cost-effectively by an ordinary person.

Abstract: A non-toxic insect repellent concentrate formulation utilizing a plurality of all natural active components has been proven to be effective in repelling mosquitoes for periods of between six to eight weeks, with one application. The insect repellent concentrate formulation includes a plurality of natural essential oils comprising at least one emulsifying agent to maintain the oils in a stable solution. A pH conditioning agent may be added to assure the formulation is pH balanced for application to grass, plants, and trees, without detriment. The formulation may be provided as either a concentrate, or at dilutions ready for direct application, and may be applied by any of a variety of methods including broadcast spraying, boom applicators, misting systems, aerosol spray devices, etc.

Abstract: Provided is a lymphatic vessel stabilizer composed of Tie2 activator. The Tie2 activator is preferably at least one type selected from the group consisting of angiopoietin 1 (Ang-1), extract of Cinnamomum species plants, extract of Siberian Ginseng and syringaresinol.

Abstract: A natural adaptogenic tea is prepared from adaptogens to counter adverse physical, chemical, or biological stressors and to promote t-cell activity and k-cell activity. Also, the composition is high in antioxidants and discourages free radicals. Moreover, the composition improves liver performance, resulting in improved toxin removal and improved nutrient absorption. In addition to these benefits, the composition improves capillary dilation, thereby providing better oxygenation to the brain. The tea is prepared from adaptogens including rhodiola, ashwagandha, schizandra berry, eleuthero and astralagus. Also, the tea includes damiana leaf, passion flower, milk thistle, white willow bark, goji berry, mangosteen, pomegranate, green tea, and sarsaparilla.

Abstract: Disclosed are compositions and corresponding methods of their use that include extracts from Loropetalum chinensis, Camptotheca acuminate, Lonicera maackii, Washingtonia filifera, Artemisia parviflora, Glochidion lanceolaris, Polygonum hydropiper, Populus davidiana, Tsoongiodendron odorum, Trema angustifolia, Ficus tikoua, Pistacia chinensis, Zizyphus mauritiana, Garuga forrestii, Michelia figo, Sabina chinensis, Cuphea balsamona, Setaria palmifolia, Polygonum lapathifolium, Machilus longipedicellata, Geranium nepalense, Ipomoea obscura, Cedrus deodara, Quercus aliena, Carqueja, Condurango, Catuaba, Carex baccans, Chrysalidocarpus lutescens, Gnaphalium pensylvanicum, Celtis sinensis, Cassia siamea, Catalpa yunnanesis, Potamogenton perforliatus, Cinnamomum japonicum, or any combination thereof.

Abstract: A dietary supplement composition having an ORAC value in excess of at least about 2,500 and which can be readily consumed in a small quantity is provided for supplementing an individual's daily intake. The dietary supplement composition suitably includes organic and/or vegan ingredients and can be consumed in quantities of as little as about 1 tablespoon to provide an amount of antioxidants equivalent to at least the minimum recommended daily intake of five to nine servings of fruits and/or vegetables.

Abstract: The present invention relates to a synergistic herbal composition for diabetes and related disorders comprising extracts of plant Eugenia of concentration ranging between 10-80% and plant Cinnamomum of concentration ranging between 10-80% optionally along with pharmaceutically acceptable excipients; a method of treating diabetes and related disorders in a subject in need thereof by administering the composition comprising extracts of plant Eugenia of concentration ranging between 10-80% and plant Cinnamomum of concentration ranging between 10-80% optionally along with pharmaceutically acceptable excipients; and a process for preparation of a synergistic herbal composition for diabetes and related disorders, wherein the process comprising steps of: (a) obtaining extracts of Eugenia and Cinnamomum separately using aqueous or organic solvents; and (b) formulating the extracts to arrive at the synergistic composition.

Abstract: The present invention relates to a composition for improving intestinal flora and enhancing immune response containing Cinnamomum cassia bark extract as an effective ingredient, more precisely, a composition containing Cinnamomum cassia bark extract is an effective ingredient that has the effects of increasing the growth of such intestinal beneficial bacteria as Bifidobacterium longum, Lacotobacillus sp. and Lactobacillus acidophilus and enhancing the proliferation of immune cells such as lymphocytes of general immune system as well as increasing the activity of intestinal immune cells. The composition of the present invention can be effectively used as a therapeutic agent for constipation or other intestine-related diseases and an immune enhancer owing to its activity of increasing immunity, particularly intestinal immunity, by increasing immune cell proliferation.

Abstract: A composition containing cinnamon extract reduces and/or eliminates one or more risk factors associated with Syndrome X. The composition also includes optionally one of more components selected from the group consisting of vitamins, cholesterol lowering agents, lipid lowering agents, and glucose lowering agent. Also described is a method of reducing and/or eliminating risk factors associated with Syndrome X in a subject through the administration of the cinnamon extract. The cinnamon extract supplement is administered orally, intravenously, or subcutaneously. In one embodiment, a daily dose of 10-1,000 mg of the cinnamon extract supplement is administered to the subject for a period of 6 weeks to 6 months.

Abstract: The invention presents nutritional supplements with anti influenza activities. In a preferred embodiment, the invention features administration to a subject an effective dose of a nutritional supplement that includes a combination of all or some of the following ingredients licorice, quercetin, green tea, cinnamon, propolis, and selenium.

Abstract: Methods and compositions comprising essential oils or components thereof for protecting harvested fruits against decay caused by a specific pathogenic fungus are provided, such as Cinnamon cassia oil for protection of persimmons against Alternaria alternata, strawberries against Botrytis cinerea, or mandarins against Penicillium italicum or Penicillium digitatum.

Abstract: Disclosed herein are non-toxic antimicrobial compositions for cleaning, reducing the bioburden and substantially killing gram negative and positive bacteria on hard surfaces. The antimicrobial compositions comprise about 0.01% to about 4.0% by weight of one or more oils selected from the group comprising rosemary oil, tea tree oil, spearmint oil, peppermint oil, clove oil, lemongrass oil, cedar oil, and cinnamon oil and about 0.1% to about 4.0% by weight of one or more acids selected from the group comprising carboxylic acids, ascorbic acid, glutamic acid, fumaric acid, oxalic acid and malonic acid. In an embodiment of the invention, an alkali base such as sodium hydroxide or potassium hydroxide is added to the above antimicrobial solution to increase the pH of the antimicrobial solution to a range of about 2.0 to about 4.0 to effect a rapid reduction of the bioburden on the hard surfaces within 5 minutes.

Abstract: A vascular maturation, normalization or stabilization agent, or a Tie-2 activation agent, is provided comprising an extract derived from a plant belonging to the genus Cinnamomum.

Abstract: A composition obtained primarily from plant materials provides antimicrobial activity for use as an anti-fungal agent. The anti-fungal agent is effective in inhibiting the growth of Trichophyton rubrum, the fungus that is the most common cause of Tinea pedis. The composition includes selective mixtures of the origanum oil, menthol, and Atlantic cedarwood oil, thuja oil, cedarwood oil, cinnamon oil, clove oil, cumin oil, fennel oil, peppermint oil, or rosemary oil.

Abstract: A skin-sensitizing formulation is provided in an edible, softgel pill. A person engaged in a sexual activity bites down on the pill, thereby effectuating the oral release of the skin-sensitizing formulation. This allows the skin-sensitizing formulation to be spread to a sexual partner, on any part of the skin or sexual region of the body preferably through oral contact with the partner. The skin-sensitizing substance is spread to the partner directly on the skin or through oral contact or beneath a condom worn by the partner. The skin-sensitizing formulation may include an essential mint oil, analog or derivative, and may further includes an enhancer, rubefacient, counterirritant, anesthetic, K-Opoid Receptor activator, or TRPM8 activator. Various inactive ingredients are also disclosed.

Abstract: The present invention provides herbal formulas, and compositions thereof, that can treat or reduce the severity, intensity, or duration of food allergy and food allergy related symptoms. The compositions may optionally include one or more adjuvants, cytokines, encapsulating materials, or pharmaceutically acceptable carriers or excipients, and may be administered prior to, during, or after the development of food allergy-related symptoms in a patient in need thereof.

Abstract: The present invention is directed to a compression bandage for the treatment of pain and inflammation, comprising a support substrate and an interpenetrating network of PVA disposed within the support substrate. The bandage provides cooling and delivery of therapeutic compounds. The bandage comprises an open cell foam matrix carrying an incorporated PVA hydrogel and optionally at least one additional therapeutic agent.